[go: up one dir, main page]

ES2062375T3 - Composiciones farmaceuticas que contienen un complejo de zinc. - Google Patents

Composiciones farmaceuticas que contienen un complejo de zinc.

Info

Publication number
ES2062375T3
ES2062375T3 ES90307400T ES90307400T ES2062375T3 ES 2062375 T3 ES2062375 T3 ES 2062375T3 ES 90307400 T ES90307400 T ES 90307400T ES 90307400 T ES90307400 T ES 90307400T ES 2062375 T3 ES2062375 T3 ES 2062375T3
Authority
ES
Spain
Prior art keywords
zinc complex
pharmaceutical compositions
compositions containing
zinc
desferrioxamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90307400T
Other languages
English (en)
Inventor
Mordechai Chevion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Application granted granted Critical
Publication of ES2062375T3 publication Critical patent/ES2062375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paper (AREA)

Abstract

UN SISTEMA DE BOMBEO 10 ES CAPAZ DE MANEJAR UNA SUSPENSION DE PULPA DE PAPEL DE CONSISTENCIA MEDIA (POR EJEMPLO CONSISTENCIA DE SOLIDOS DE APROXIMADAMENTE 8-15%), UTILIZANDO UNA BOMBA CENTRIFUGA CONVENCIONAL 12. UN SISTEMA DE BOMBA CONVENCIONAL CAPAZ DE MANEJAR PULPA DE CONSISTENCIA DE 3-8% PUEDE SER SUPER-EQUIPADO PARA MANEJAR PULPA DE CONSISTENCIA DE 8-15%. UN TUBO 30 CON ALABES 33 Y QUE TIENE UN EXTREMO ABIERTO 37, SE EXTIENDE A TRAVES DE LA ENTRADA 15 A LA BOMBA DE MODO QUE HAY UNA PEQUEÑA HOLGURA 35 ENTRE LOS ALABES Y LA ENTRADA Y DE MODO QUE EL EXTREMO ABIERTO ESTA CONTIGUO PERO ESPACIADO DEL CUBO 18 DEL IMPULSOR 17 DE LA BOMBA. UN PASO DE GAS 48 SE EXTIENDE DESDE EL INTERIOR HUECO DEL TUBO HASTA UN AREA ALEJADA DE LA BOMBA. EL TUBO ES ROTADO EN DIRECCION OPUESTA A LA DIRECCION DE ROTACION DEL IMPULSOR DE LA BOMBA, Y A UNA VELOCIDAD SUFICIENTE PARA FLUIDIFICAR PULPA DE UNA CONSISTENCIA DE APROXIMADAMENTE 8-15%, Y FORZAR LA PULPA HACIA LA BOMBA. EL GAS QUE SE ACUMULA EN EL IMPULSOR DELA BOMBA SE RETIRA A TRAVES DEL TUBO Y DEL PASO DE GAS EN UN ARBOL 39 CONECTADO AL TUBO, Y A ESTE FIN PUEDE UTILIZARSE UNA BOMBA DE VACIO 52.
ES90307400T 1989-07-19 1990-07-06 Composiciones farmaceuticas que contienen un complejo de zinc. Expired - Lifetime ES2062375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL91047A IL91047A (en) 1989-07-19 1989-07-19 Zinc complexes for the treatment of free radical- induced diseases

Publications (1)

Publication Number Publication Date
ES2062375T3 true ES2062375T3 (es) 1994-12-16

Family

ID=11060194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90307400T Expired - Lifetime ES2062375T3 (es) 1989-07-19 1990-07-06 Composiciones farmaceuticas que contienen un complejo de zinc.

Country Status (6)

Country Link
US (1) US5075469A (es)
EP (1) EP0409452B1 (es)
AT (1) ATE101594T1 (es)
DE (1) DE69006654T2 (es)
ES (1) ES2062375T3 (es)
IL (1) IL91047A (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
IL106064A (en) * 1993-06-18 1997-11-20 Yissum Res Dev Co Gallium complexes for the treatment of free radical-induced diseases
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto
US6140305A (en) * 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) * 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
ATE335759T1 (de) 1997-06-13 2006-09-15 Bio Rad Laboratories Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
ES2507070T3 (es) 2006-02-03 2014-10-14 Omp, Inc. Tratamiento antienvejecimiento utilizando composiciones de cobre y zinc
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
EP3189836B1 (en) 2009-08-19 2024-01-17 Mordechai Chevion Desferrioxamine-metal complexes for the treatment of immune-related disorders
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
CA2913413C (en) 2013-06-06 2021-11-23 Amip, Llc Iron supplement
US20190022103A1 (en) 2014-12-22 2019-01-24 Mordechai Chevion New metal complexes of nocardamine and their use in pharmaceutical compositions
KR20180105701A (ko) 2016-02-11 2018-09-28 모데차이 체비온 신경변성의 치료를 위한 방법 및 약학 조성물
JP2021521209A (ja) * 2018-04-15 2021-08-26 モデハイ シェヴィオンCHEVION, Mordechai 鉄過剰症の治療のための組成物及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554690A (en) * 1944-06-13 1951-05-29 Squibb & Sons Inc Zinc-penicillin and preparation thereof
US3297531A (en) * 1963-12-11 1967-01-10 Ernst A H Friedheim Complexes of trivalent antimony with penicillamine, and admixtures of excess penicillamine with said complexes
ATE98631T1 (de) * 1988-01-20 1994-01-15 Ciba Geigy Ag Verfahren zur herstellung von komplexverbindungen.

Also Published As

Publication number Publication date
IL91047A (en) 1993-06-10
ATE101594T1 (de) 1994-03-15
EP0409452B1 (en) 1994-02-16
DE69006654T2 (de) 1994-05-26
DE69006654D1 (de) 1994-03-24
US5075469A (en) 1991-12-24
EP0409452A1 (en) 1991-01-23
IL91047A0 (en) 1990-02-09

Similar Documents

Publication Publication Date Title
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
EG17753A (en) Novel pharmacological compounds
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
GR3004966T3 (es)
FI931031A0 (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
SE8404065D0 (sv) Novel biologically active compounds
IT1228288B (it) Composti ad attivita' antiserotoninica
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
SE8600658D0 (sv) Novel composition of matter
DE69017969D1 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
IL85560A0 (en) Pharmaceutical compositions containing an antidepressant and a synergist
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.
IT8720701A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
IT8720229A0 (it) Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina
IT8621925A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
AU4431493A (en) Antirheumatic composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 409452

Country of ref document: ES